Dr. Reddy - Betapharm Deal Ya No Deal – Team 1 Pre- Deal Deal Other Bidders Betapharm Dr. Reddy Labs Perfect Pharma Acquisition Rationale Limitations in India Access to…

1. SYNCOPEA systematic and evidence based approachAnne-Marie de Vries 2. Case76 Years old ♂Sudden LOC, without prodromal symptomsOn his way from the couch to the fridge…

Slide 1Ten-year follow-up analysis of the BCIRG 001 trial confirms superior DFS and OS benefit of adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide) over FAC (fluorouracil,…

Slide 1Chemoprevention of Ovarian Cancer: Is There a Role for Diet and Physical Activity Interventions? David S. Alberts, M.D. Slide 2 Background The five year relative survival…

Slide 1Patients research priorities in gastrointestinal disease Mark Welfare Gastroenterologist, Senior Lecturer at University of Newcastle Slide 2 Acknowledgements Co-researchers:…

Slide 1Recent advances in Radiotherapy of CNS Tumours Dr Vivek Bansal Director, Dept of Radiation Oncology HCG Cancer Centre,Sola Ahmedabad,Gujarat,India Email : [email protected]…

Slide 1Informational Technology for Personalized Medicine John D. Halamka, MD, MS CIO, CareGroup and Harvard Medical School Slide 2 New Technologies Google Health Microsoft…

Slide 1Management of Non Muscle Invasive Bladder Cancer Manish I. Patel Associate Professor, University of Sydney And Urological Cancer Surgeon Westmead and Sydney Adventist…

1.The case of the sassy blistering woman Andy J. Chien University of Washington Department of Medicine Division of Dermatology 2. Introducing J.M. • ID: 65 yo F with two…

1. FUTURELABA quick “fix” on PharmacyRetailing beyond 2009Prepared by: Scott McLaughlin, Melbourne, Australia.November , 2009 1 2. FUTURELAB In the last 15 Years Patients…